Cargando…
An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113507/ https://www.ncbi.nlm.nih.gov/pubmed/35591901 http://dx.doi.org/10.1093/rap/rkac035 |
_version_ | 1784709597139828736 |
---|---|
author | Lee, Jeanie Bizzocchi, Lilian Jain, Ruchi Tagoe, Clement E |
author_facet | Lee, Jeanie Bizzocchi, Lilian Jain, Ruchi Tagoe, Clement E |
author_sort | Lee, Jeanie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9113507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91135072022-05-18 An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab Lee, Jeanie Bizzocchi, Lilian Jain, Ruchi Tagoe, Clement E Rheumatol Adv Pract Letter to the Editor (Case report) Oxford University Press 2022-05-09 /pmc/articles/PMC9113507/ /pubmed/35591901 http://dx.doi.org/10.1093/rap/rkac035 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor (Case report) Lee, Jeanie Bizzocchi, Lilian Jain, Ruchi Tagoe, Clement E An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title | An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title_full | An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title_fullStr | An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title_full_unstemmed | An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title_short | An autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab |
title_sort | autoinflammatory syndrome with compound heterozygous mefv and nod2/card15 gene mutations successfully treated with tocilizumab |
topic | Letter to the Editor (Case report) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113507/ https://www.ncbi.nlm.nih.gov/pubmed/35591901 http://dx.doi.org/10.1093/rap/rkac035 |
work_keys_str_mv | AT leejeanie anautoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT bizzocchililian anautoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT jainruchi anautoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT tagoeclemente anautoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT leejeanie autoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT bizzocchililian autoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT jainruchi autoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab AT tagoeclemente autoinflammatorysyndromewithcompoundheterozygousmefvandnod2card15genemutationssuccessfullytreatedwithtocilizumab |